In a recent study, synaptotagmin 2 was significantly reduced in postmortem brain tissue of Alzheimer’s disease patients and reliably discriminated Alzheimer’s disease from Parkinson’s disease dementia [314]. This evidence concerns the gene SYT2 and Alzheimer disease.